Ibuliq

Ibuprofen, the active ingredient in Ibuliq, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the relief of mild to moderate pain, reduction of fever, and management of inflammatory conditions such as arthritis in adults and children when appropriate.

GNH USA supplies Ibuliq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Ibuliq (ibuprofen) acts on the cyclooxygenase pathway to alleviate symptoms associated with several common conditions.

- Pain (mild to moderate): Provides analgesic relief for headaches, dental pain, musculoskeletal aches, and dysmenorrhea. - Fever: Lowers elevated body temperature associated with infections or inflammatory processes. - Inflammation (e.g., osteoarthritis, rheumatoid arthritis): Reduces swelling and improves joint mobility.

Adverse reactions to ibuprofen may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or acute kidney injury. - Severe hypersensitivity reactions such as Stevens‑Johnson syndrome or anaphylaxis.

When using ibuprofen, consider the following safety measures.

- Assess renal function: monitor patients with pre‑existing kidney disease. - Evaluate cardiovascular risk: use caution in individuals with hypertension or heart disease. - Review gastrointestinal history: avoid in patients with active ulcers or bleeding disorders. - Check for asthma sensitivity: ibuprofen may exacerbate bronchospasm in aspirin‑sensitive asthma. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose corticosteroids: heightened gastrointestinal ulcer risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Diuretics: potential for decreased antihypertensive effect and renal impairment. - Selective serotonin reuptake inhibitors (SSRIs): modestly increased bleeding tendency.